薬物動態
Print ISSN : 0916-1139
Effect of Biliary Excretion on the Pharmacokinetics of Pitavastatin (NK-104) in Dogs
Junji KOJIMATakeshi OHSHIMAMichiaki YONEDAHironobu SAWADA
著者情報
ジャーナル フリー

2001 年 16 巻 6 号 p. 497-502

詳細
抄録

The disposition of pitavastatin and pitavastatin lactone, which are mutually converted in the circulatory system, was investigated after intravenous administration of pitavastatin in dogs equipped with chronic bile-duct catheters.
The plasma concentration of pitavastatin declined three-exponentially after dosing in the dogs with both diverted and non-diverted bile-flow. The terminal elimination half-life (T1/2) of pitavastatin in the diverted and non-diverted conditions was 3.12 and 5.01 hr, and that of pitavastatin lactone 4.50 and 7.23 hr, respectively. The diverted bile-flow decreased the AUC0-24 hr for pitavastatin and its lactone to 66 and 64%, respectively.
In the dogs with the diverted bile-flow, 56.1% and 4.2% of the dose was recovered in the bile as pitavastatin and its lactone, respectively. The biliary clearance (CLb) of pitavastatin and its lactone was 32.5 and 6.8 mL/min, respectively, and the CLb of pitavastatin was about 4.8-fold that of its lactone.
In the dogs whose bile-flow was not diverted, the cumulative biliary excretion of pitavastatin and its lactone was estimated from the AUC0-24 hr and CLb of both forms of pitavastatin. The estimated amount was increased by 46% compared with that in the dogs with the diverted bile-flow. This indicates that the increase reflects the actual contribution of the enterohepatic circulation.

著者関連情報
© The Japanese Society for the Study of Xenobiotics
次の記事
feedback
Top